In-stent Restenosis Clinical Trial
Official title:
CIVILIAN Study in Femoropopliteal Artery Occlusion Disease
Peripheral arterial disease (PAD) carries a significant global health burden, and can limit functional capacity and quality of life. Percutaneous transluminal angioplasty (PTA) for PAD is often associated with suboptimal outcomes due to complications following balloon inflation related to vessel trauma and flow limiting dissections that may require bailout stenting. Different strategies and techniques to enhance both acute and longer-term outcomes with drug-coated balloons (DCB) are needed. This is a national, prospective, multi-center, non-randomized, real-world study to evaluate the safety and efficacy of multiple vessel preparation strategies combined with drug-coating balloon (DCB) in Femoropopliteal Artery (F-PA) lesions.
Femoropopliteal artery occlusive disease is a common type of peripheral arterial disease (PAD). Hitherto, endovascular treatment has been testified and advocated as the first-line treatment of femoropopliteal occlusive disease. However, the in-stent restenosis has been a major limitation of well long-term patency rate in this segment due to physiological and geometrical issues. The concept "leave nothing behind" is proposed, and some vessel preparation methods and devices, such as directional atherectomy, rotational atherectomy, laser atherectomy are developed. This is a national, prospective, multi-center, non-randomized study to evaluate the safety and efficacy of multiple vessel preparation strategies combined with drug-coating balloon (DCB) in Femoropopliteal Artery (F-PA) lesions. A total of 1000 patients will be included in approximately 8 sites. The study is designed to demonstrate the inferiority of different vessel preparation strategies in various fields under long-term follow-up. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00341562 -
Genomics of In-Stent Restenosis
|
N/A | |
Completed |
NCT05509296 -
Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery Disease
|
N/A | |
Not yet recruiting |
NCT06090890 -
Anti-inflammatory Therapy for Recurrent In-stent Restenosis
|
Phase 4 | |
Active, not recruiting |
NCT00998439 -
Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter
|
Phase 2 | |
Active, not recruiting |
NCT05731700 -
CVT-ISR First in Human Trial for Coronary In-Stent Restenosis
|
N/A | |
Completed |
NCT03260517 -
The PREVAIL Study
|
N/A | |
Not yet recruiting |
NCT03588962 -
Metal Allergy In-Stent Restenosis Study
|
N/A | |
Completed |
NCT00393315 -
P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses
|
Phase 2 | |
Recruiting |
NCT03874481 -
The Effect of Sleep Quality on Coronary Artery Disease and In Stent Restenosis
|
||
Active, not recruiting |
NCT01127958 -
DARE-trial: A Trial Studying the Effect of the SeQuent Please Drug-eluting Balloon Compared to the Xience Prime Drug-eluting Stent for the Treatment of Stenosis of an Earlier Implanted Stent.
|
N/A | |
Active, not recruiting |
NCT04647253 -
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)
|
Phase 3 | |
Active, not recruiting |
NCT03529006 -
Absorb Bioresorbable Scaffold vs. Drug Coated Balloon for Treatment Of In-Stent-Restenosis
|
N/A | |
Completed |
NCT00485030 -
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
|
Phase 4 | |
Not yet recruiting |
NCT03809754 -
Optical Coherence Tomography Guided Percutaneous Coronary Intervention for Drug-eluting In-stent Restenosis
|
N/A | |
Completed |
NCT00916279 -
PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis
|
Phase 1/Phase 2 | |
Recruiting |
NCT01239940 -
RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)
|
Phase 4 | |
Active, not recruiting |
NCT01239953 -
RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)
|
Phase 4 | |
Not yet recruiting |
NCT06148441 -
Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention
|
||
Completed |
NCT05512832 -
In-stent Restenosis and Pericoronary Fat Attenuation Index
|
||
Recruiting |
NCT03521843 -
LDD in Treatment of Femoropopliteal ISR
|
N/A |